Endocrine Abstracts

Previous issue | Volume 110 | ECEESPE2025

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

Rapid Communications

Rapid Communications 9: Endocrine Related Cancer

Previous section
Rapid Communications 8: Diabetes and Insulin Part 2

Table of contents

Next section
Rapid Communications 10: Pituitary, Neuroendocrinology and Puberty Part 2

ea0110rc9.1 | Rapid Communications 9: Endocrine Related Cancer

Hereditary duodenopancreatic neuroendocrine tumors, what genetic analysis? a retrospective analysis on 410 patients

ea0110rc9.2 | Rapid Communications 9: Endocrine Related Cancer

Dysregulation of a RNA exosome component: a driving force behind prostate cancer progression

ea0110rc9.3 | Rapid Communications 9: Endocrine Related Cancer

Defining the clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and exploitable therapeutic target

ea0110rc9.4 | Rapid Communications 9: Endocrine Related Cancer

Adipsic arginine vasopressin deficiency in CNS tumour patients: clinical management challenges

ea0110rc9.5 | Rapid Communications 9: Endocrine Related Cancer

Preclinical development and first clinical use of a radioiodinated CYP17 inhibitor for adrenal theranostics

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more